Ovary tissues were fixed with 10% formalin. Subsequently, the tissues were embedded in paraffin and cut into sections (4 μm thick). To investigate the distribution of ovarian follicles in the ovaries, the prepared tissues were stained with hematoxylin and eosin (H&E), photographed, and scored in a blinded fashion by using light microscopy (BX51; Olympus, Tokyo, Japan). Images were captured by using an Olympus DP controller and manager at ×40, ×100, and ×200 magnification.
Dp controller and manager
Manufactured by Olympus
Sourced in Germany
The DP controller and manager is a component designed to manage and control digital imaging devices. It provides the core functionality to interface with and regulate the operation of digital cameras, microscopes, and other imaging equipment. The device enables users to capture, process, and manage digital images through a standardized interface.
Automatically generated - may contain errors
Lab products found in correlation
3 protocols using dp controller and manager
1
Ovarian Follicle Distribution Analysis
2
Histological Evaluation of Skin Tissue
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Skin tissue slices were fixed in 10% neutral buffered formalin (BIOSESANG, Gyeonggi-do, Korea) for 24 h at 4 °C, paraffin-embedded, sectioned, and stained with hematoxylin and eosin (H&E) or toluidine blue (TB) for the detection of the epidermal thickness and mast cells, respectively. Images were captured using an Olympus DP controller and manager at X100. The mast cells were counted in five high-power fields (HPF) at X200.
3
Immunohistochemical Evaluation of Leukemia
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Histology and immunohistochemistry were conducted using an Olympus DP controller and manager (Leica, Germany). Morphological detection aligns with prior publications (9 (link), 28 (link)). The markers used for immunohistochemistry to evaluate the individual samples of each patient were based on the types of leukemia. Specifically, for acute lymphoblastic leukemia patients, we used CD10, CD79a, CD3, and TdT antibodies. For acute myeloid leukemia patients, we employed CD34, CD117, and MPO antibodies. All assessments were conducted by experienced pathologists.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!